GILEAD SCIENCES, INC. — Director's Dealing 2017

May 3, 2017

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: GILEAD SCIENCES INC (GILD)
CIK: 0000882095
Period of Report: 2017-05-01

Reporting Person: Alton Gregg H (EVP Comm&Acs ALA, Corp&Med Aff)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2017-05-01	Common Stock	S	5000	$68.3058	Disposed	112988	Direct

Footnotes

F1: The sale transaction reported in this Form 4 is made pursuant to a Rule 10b5-1 trading plan.

F2: Sale prices reported for the transactions reported here range from $68.06 to $68.74. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer or its shareowners upon request.